导航前方的道路:评估针对发作商业司机的国际指导方针
Liam Mulcahy1, Nicholas Lawn2, John Dunne3
1Sir Charles Gairdner Hospital, Hospital Ave, Nedlands, Perth, WA 6009, Australia.
Epilepsy & behavior : E&B
|January 29, 2025
概括
对患者的商业驾驶资格标准缺乏全球统一性. 对和发作类型的指导方针有很大差异,许多国家缺乏明确的政策或实施终身禁令.
科学领域:
- 神经学 神经学
- 公共卫生政策 公共卫生政策
- 运输安全运输安全
背景情况:
- 对于患有发作障碍的人来说,商业驾驶资格对于公共安全和患者的生计至关重要.
- 与和发作有关的商业驾驶执照 (CDL) 的现有规定缺乏国际标准化.
- 准则的变化可能源于对风险的不同解释和有限的基于证据的数据.
研究的目的:
- 系统地评估患者商业驾驶资格标准的全球可用性和一致性.
- 为了比较不同国家对的规定,第一次急性症状和第一次无缘无故的.
主要方法:
- 对患有和发作疾病的患者进行了商业驾驶执照法规的系统审查.
- 数据来自政府驾驶机构网站和公布的指导方针.
- 当官方指导方针无法使用时,当地神经科医生被联系.
主要成果:
- 有112个国家的信息,其中76%是通过官方来源获得的,24%是通过直接联系获得的.
- 对于,85个国家有指导方针:42个国家要求5-10年没有,43个国家规定终身禁令,27个国家没有指导方针.
- 在所有型中观察到无期 (6个月至10年),终身禁令和医疗评估要求 (MRI,EEG,药物,神经科医生输入) 的显著差异.
结论:
- 国际商业驾驶执照指南中对于症患者而言存在相当大的不统一性.
- 这种不一致性凸显出需要基于证据的政策制定,这可能需要更多的长期数据.
- 标准化,数据驱动的指导方针对于驾驶法规的一致和公平的应用至关重要.
更多相关视频
05:33A Model for Epilepsy of Infectious Etiology using Theiler's Murine Encephalomyelitis Virus
Published on: June 23, 2022
2.7K
11:12Driving Simulation in the Clinic: Testing Visual Exploratory Behavior in Daily Life Activities in Patients with Visual Field Defects
Published on: September 18, 2012
17.3K
相关概念视频
01:24Arteries of the Lower Limbs
177
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
177
01:13Seizures: Classification
299
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
299
01:07Narcolepsy
89
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
89
01:20Antiepileptic Drugs: Potassium Channel Activators
142
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
142
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
221
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
221
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
316
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
316